YUNNAN BAIYAO
LIVE

Serial Number

78943940

Owner

Yunnan Baiyao Group Co., Ltd.

Attorney

Michael T. Smith

First Use Date

Mar 15, 2006

Filing Date

Aug 3, 2006

Add to watchlist:

No watchlists yet
View on USPTO

YUNNAN BAIYAO Trademark

Serial Number: 78943940 • Registration: 3496078

YUNNAN BAIYAO is a trademark filed by Yunnan Baiyao Group Co., Ltd. on August 3, 2006. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

Yunnan Baiyao Group Co., Ltd. (20 trademarks)

3686, Yunnan Baiyao Road
Yunnan . , CN

Entity Type: 03

Trademark Details

Filing Date

August 3, 2006

Registration Date

September 2, 2008

First Use Anywhere

March 15, 2006

First Use in Commerce

March 15, 2006

Published for Opposition

June 17, 2008

Goods & Services

Coffee; cocoa; coffee substitutes; tea; tea substitutes; sugar; candy; non medicated chewing gum; honey; herbal food beverages; alimentary paste; alimentary powder, namely, ginseng powder and panaxnotoginseng powder used as a spice, herb or flavoring; non medicated royal jelly for human consumption; chicken essence with aweto extracts as flavoring; bee pollen paste; bread; cakes; pastries; cereal preparations, namely, breakfast cereals, cereal based snack foods, and processed cereals; noodles; popcorn; soya flour; starch products for food, namely, corn starch, rice starch flour and wheat starch flour; ice cream; cooking salt; vinegar; soya sauce; seasonings; yeast; food flavorings, namely, non essential oils; meat tenderizers for household purposes

Medicines for human purposes, namely, medicines for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; capsules for pharmaceutical purposes, namely, capsules for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; nervines, namely, nerve calming preparation and pharmaceutical preparations acting on the central nervous system; germicides; medicinal herbs, namely, medicinal herbs in extract form and dried medicinal herbs; pharmaceutical preparations for bleeding arresting; biological preparations for medical purposes; pharmaceutical preparations, namely, appetite suppressants; medicines for dental purposes, namely, medicines for use in treatment of pain in the gums and periodontia; edible plant fibres, namely, plant extracts for medical and pharmaceutical purposes; raw medicines, namely, raw materials pharmaceuticals, namely, medicinal herbal extracts for medical purposes, vitamin and mineral preparations for use as ingredients in the pharmaceutical industry; Chinese patent medicines for use in the treatment of traumatic injuries, bleeding wounds, gynecological diseases, epistaxis, bronchial dilating, pulmonary tuberculosis, pneumonia, gastrointestinal tract hemorrhage, arrest bleeding, anti inflammation, healing of a wound, chilblain, help healing of fracture, motor impairment, pain from rheumatism, injury of bones, joints and soft tissue, mosquito and insect bites, swelling and pain due to blood stasis, and lumbar muscle strain; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff, namely, dandruff shampoo and dandruff conditioner; herbal pastes used for stopping bleeding, relieving pain and anti inflammatory purposes; poultices; radioactive medicines, namely, radioactive substances for use in nuclear medicine; gases for medical purposes; chemical conductors for electrocardiograph electrodes; human semen for artificial insemination; sanitary sterilizing preparations; solutions for contact lenses; nutritive substances for microorganism cultures; dietetic foods adapted for medical purposes; dietetic food preparations adapted for medical purposes, namely, dietetic beverages for treatment of trace elements, that is, iron, zinc, calcium, deficiency diseases; nutritional additives for use in foods and dietary supplements for human consumption for medical purposes; infant milk powder; air deodorizer and air freshening preparations; medicines for veterinary purposes, namely, veterinary medicines for treatment of intestinal bacteria, relieving pain, anti infective and veterinary vaccines; pesticides; herbicides; sanitary towels, namely, sanitary napkins and sanitary pads; sterile paper towel, namely, medicated pre-moistened towelettes; adhesive plaster for medical purposes; gummed plaster for medical purposes; medical dressings, namely, gauze and cotton for medical purposes; surgical dressings; surgical tissues, namely, surgical dressings and surgical bandages; first aid kits; teeth filling material; aerosol, namely, an external analgesic aerosol used for relieving pain and anti-inflammatory purpose; anti microbial hand wash; diet capsules; processed ginseng, panaxnotoginseng, pollen or bird's nest used as an herbal supplement; alimentary powder, namely, ginseng powder and panaxnotoginseng powder for medicinal use

Hair lotions; disinfectant soap; shampoos; cakes of toilet soap; non medicated bath salts; hand cleaner; facial cleansing lotion; bath lotion; washing preparations, namely, washing powders and liquids for clothing, kitchen use, laundry, dishes, and hands; stain removers; polishing preparations; cleaning and shining preparations, namely, polish, for furniture, floors and leather; grinding preparations, namely, general purpose polishing and abrasive liquids and powders; essential oils for cosmetic purposes; rose oil for cosmetic purposes; industrial perfumes, namely, perfumes for the manufacture of cosmetic preparations; cosmetic aromatic ingredients, namely, perfumery and perfume oils; beauty masks; skin whitening creams; make up preparations; cosmetics; make up removers; toilet water; oils for cosmetic purposes; lotions for cosmetic purposes; cosmetic preparations for slimming purposes, namely, creams for cellulite reduction and lotions for cellulite reduction; cosmetic sun tanning preparations for protecting the skin from the sun; anti wrinkle creams; anti freckle creams; non medicated mouth washes; dentifrices; denture cleaners; denture polishes; breath freshening sprays; incense; fragrant potpourri; cosmetics for animals

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 21, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 21, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 21, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 21, 2020 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 24, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 24, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 24, 2018 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 24, 2018 APRE
TEAS SECTION 8 & 9 RECEIVED
Jul 11, 2018 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 2, 2017 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 10, 2013 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 10, 2013 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 10, 2013 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Oct 3, 2013 815F
TEAS SECTION 8 & 15 RECEIVED
Oct 3, 2013 E815
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 30, 2009 COC.
ASSIGNED TO PARALEGAL
Oct 2, 2008 PLGL
TEAS SECTION 7 REQUEST RECEIVED
Sep 10, 2008 ES7R
REGISTERED-PRINCIPAL REGISTER
Sep 2, 2008 R.PR
PUBLISHED FOR OPPOSITION
Jun 17, 2008 PUBO
NOTICE OF PUBLICATION
May 28, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 14, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2008 TROA
NON-FINAL ACTION MAILED
Mar 11, 2008 CNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2008 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 10, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 11, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 29, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2008 TROA
NON-FINAL ACTION MAILED
Aug 29, 2007 CNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2007 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 28, 2007 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 17, 2007 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 6, 2007 PREV
ASSIGNED TO LIE
Aug 6, 2007 ALIE
EXAMINERS AMENDMENT MAILED
Jun 22, 2007 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 21, 2007 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 21, 2007 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 21, 2007 ZZZX
EXAMINERS AMENDMENT MAILED
Jun 21, 2007 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2007 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 20, 2007 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 20, 2007 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2007 TROA
NON-FINAL ACTION MAILED
Dec 19, 2006 CNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2006 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2006 DOCK
NEW APPLICATION ENTERED
Aug 8, 2006 NWAP